Javascript must be enabled to continue!
IN VITRO STUDIES OF ULCERATIVE COLITIS
View through CrossRef
By means of immunofluorescent methods it has been shown that sera from children with ulcerative colitis contain antibodies which react with fetal colon cells in tissue culture. 5 out of 13 sera from patients reacted positively when tested for staining antibodies while 12 sera from healthy individuals yielded negative results. The specificity of the staining reactions was confirmed by inhibition experiments. The staining capacity of various sera was correlated to their hemagglutinating titer when tested against phenol-water extracts of human colon.
The presence of blood group substances of the ABO system on fetal colon cells in tissue culture could be demonstrated by application of fluorescent H agglutinins from eel. Cross-inhibition experiments indicated that the H agglutinins stained colon antigens which were different from those reacting with the antibodies of ulcerative colitis sera.
The reactivity of cultured fetal colon cells with the antibodies in ulcerative colitis sera was retained for up to 12 days, with optimal staining at 4 to 5 days. Reactivity with H agglutinins was present for a longer period, sometimes more than 20 days.
Although antigen could be shown to be present on fetal colon cells in tissue culture, exposure of the culture, in the presence of fresh guinea pig serum, to sera from patients with ulcerative colitis did not lead to any visible cytotoxic damage. In order to investigate the possible cytotoxic effect of the sera with a more sensitive technique, freshly explanted fetal colon was dispersed by trypsinization and the cells labeled with 32P-orthophosphate. Subsequently, these cells were exposed to sera, in a final concentration of 30 per cent, from patients or healthy controls in the presence of fresh guinea pig serum (final concentration 15 per cent). Approximately 20 per cent of the cellular isotope was released into the medium within 150 minutes of incubation, but the release was the same in the samples treated either with patients' sera or normal control sera. Thus, under the present conditions, the patients' sera did not exert any specific cytotoxic action on colon cells.
Title: IN VITRO STUDIES OF ULCERATIVE COLITIS
Description:
By means of immunofluorescent methods it has been shown that sera from children with ulcerative colitis contain antibodies which react with fetal colon cells in tissue culture.
5 out of 13 sera from patients reacted positively when tested for staining antibodies while 12 sera from healthy individuals yielded negative results.
The specificity of the staining reactions was confirmed by inhibition experiments.
The staining capacity of various sera was correlated to their hemagglutinating titer when tested against phenol-water extracts of human colon.
The presence of blood group substances of the ABO system on fetal colon cells in tissue culture could be demonstrated by application of fluorescent H agglutinins from eel.
Cross-inhibition experiments indicated that the H agglutinins stained colon antigens which were different from those reacting with the antibodies of ulcerative colitis sera.
The reactivity of cultured fetal colon cells with the antibodies in ulcerative colitis sera was retained for up to 12 days, with optimal staining at 4 to 5 days.
Reactivity with H agglutinins was present for a longer period, sometimes more than 20 days.
Although antigen could be shown to be present on fetal colon cells in tissue culture, exposure of the culture, in the presence of fresh guinea pig serum, to sera from patients with ulcerative colitis did not lead to any visible cytotoxic damage.
In order to investigate the possible cytotoxic effect of the sera with a more sensitive technique, freshly explanted fetal colon was dispersed by trypsinization and the cells labeled with 32P-orthophosphate.
Subsequently, these cells were exposed to sera, in a final concentration of 30 per cent, from patients or healthy controls in the presence of fresh guinea pig serum (final concentration 15 per cent).
Approximately 20 per cent of the cellular isotope was released into the medium within 150 minutes of incubation, but the release was the same in the samples treated either with patients' sera or normal control sera.
Thus, under the present conditions, the patients' sera did not exert any specific cytotoxic action on colon cells.
Related Results
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Ulcerative colitis is a multifactorial, chronic inflammatory disease of the bowel that can cause physical, social and emotional injury to the patient. While perhaps not always maki...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...
Anemia in Patients with Ulcerative Colitis in Remission: A Cross-Sectional Study from Pakistan
Anemia in Patients with Ulcerative Colitis in Remission: A Cross-Sectional Study from Pakistan
Background and Aim: Anemia is an extra intestinal manifestation of inflammatory bowel disease that frequently causes complications. In inflammatory bowel disease (IBD) such as ulce...
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
P0100 Role of Ethyl Pyruvate on Large Intestinal Inflammatory and Oxidative Markers in TNBS-Induced Colitis
Abstract
Background
Ethyl pyruvate (EP), with anti-inflammatory and antioxidant effects, has shown therapeutic potential ...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...
Ulcerative Colitis Ocular Manifestations in Patients Admitted to a Peshawar Tertiary Care Hospital
Ulcerative Colitis Ocular Manifestations in Patients Admitted to a Peshawar Tertiary Care Hospital
Objective: This study aimed to see how common ocular symptoms of ulcerative colitis were in patients hospitalized in a tertiary care hospital in Peshawar. Methodology: At Hayatabad...
P0518 Study of the prevalence of defecatory disorders in patients with quiescent ulcerative colitis using high resolution anorectal manometry
P0518 Study of the prevalence of defecatory disorders in patients with quiescent ulcerative colitis using high resolution anorectal manometry
Abstract
Background
Ulcerative colitis is characterized by recurring episodes of inflammation limited to the mucosal layer of th...
Dual-pathway mechanisms of plant-derived polysaccharides in ulcerative colitis: integrative roles of microbiota modulation, immune regulation, and barrier restoration
Dual-pathway mechanisms of plant-derived polysaccharides in ulcerative colitis: integrative roles of microbiota modulation, immune regulation, and barrier restoration
Chronic inflammation of the colon has been described as an inflammatory condition of the colon that is characterized by recurring flare-ups of the disease (ulcerative colitis). Ulc...

